01
Why DAC was invented
Binding to albumin (the DAC idea) is a half-life trick. It is clever chemistry. It is not a 503A ticket.
- ·Pharmacokinetic story
- ·Legal story is still no
- ·See No DAC page
RE GEN RX · peptides / CJC-1295 With DAC
No lawful pathway
CJC-1295 With DAC
An extended-half-life GHRH analog — same legal answer as No DAC: not orderable.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Extended-half-life analog
What is CJC-1295 With DAC?
The molecule, in plain language.
CJC-1295 with DAC was designed for a longer GH-stimulating window. It is still a GHRH analog without a lawful §503A bulk-eligibility basis we can use. Longer half-life does not change the compounding answer.
How people usually take it. Not orderable.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
02
Not sermorelin
Patients mix the names because both are GHRH-related. Only sermorelin has a documented basis we can use today.
- ·Different molecules
- ·Different legal status
- ·Read sermorelin
03
No stacks
DAC CJC plus ipamorelin is equally blocked.
- ·2X blend page
- ·Tesamorelin/ipamorelin blend page
- ·We will not compound either
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
Long-acting GHRH analog work exists in preclinical literature.
- ·Half-life extension is not approval
- ·Not orderable
- ·No research-chemical sourcing
Human research
Limited human research does not open 503A compounding at RE GEN.
- ·Not orderable
- ·Do not pulse a research vial
- ·Ask for what is carried
Legal basis at RE GEN · July 2026
We will not compound this today.
Not nominated / no lawful §503A pathway at this time. We will not compound CJC-1295 With DAC.
We will not compound this. Ask us what is carried instead.
Common questions
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is CJC-1295 with DAC?
A longer-acting GHRH analog. Not orderable at RE GEN today.
Is CJC-1295 with DAC FDA-approved?
CJC-1295 with DAC is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get CJC-1295 with DAC at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound CJC-1295 with DAC today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Can I request sermorelin instead?
Yes — that is the GHRH analog with a documented basis. A clinician still decides.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Related on this menu
Illinois practice · licensed 503A compounding
We will tell you no — and show you what is carried instead.
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.